 |
| Jen Dobrzelecki |
Goodfuse Communications president Jen Dobrzelecki has moved to Padilla, where she will join the agency’s healthcare practice as senior vp and group lead.
Before coming on board at Goodfuse (a GCI Group company), Dobrzelecki led Lewis Global Communications’ New York office, served as US head of M&C Saatchi PR and held leadership positions at Affect, Golin and CKPR.
At Padilla, she will leverage her brand building and strategy, patient advocacy and issues management skills to help develop communications strategies and solutions for clients.
“Jen has the valuable experience and diverse skillset necessary to successfully counsel Padilla’s health clients to help build, grow and protect their brands and reputations, making her an excellent addition to the practice and Padilla’s Senior Leadership Group,” said Padilla president Matt Kucharski.
Padilla ranked #17 on O’Dwyer’s 2022 list of healthcare firms, with $8.45 million in 2021 net fees.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
